Skip to main content
OpenTrials
Completed

NCT Number: NCT05216016

Minnesota RETAIN Phase 2 (Sub-study)

MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant.

(Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Injuries Related Work Disability Illness Related Work

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > 18-years-old
  • MN Resident
  • Works in MN
  • Employed at the time of enrollment
  • Within 6 months of last day of work
  • Meets one of the following:
  • Provider work restrictions of unable to work for at least 4 weeks
  • Per healthcare team anticipated to be unable to work for at least 4 weeks
  • Employer's inability to accommodate current work restrictions
  • Meets one of the following:
  • Diagnosis of a work related or personal injury or illness that impacts employment
  • Invasive procedure (e.g., surgery) anticipated within the next 4-weeks that impacts employment
  • Documentation of work restrictions (i.e., written note/form documentation in electronic medical record prior to enrollment)

Exclusion criteria

  • Legal representation/litigation at the time of enrollment related to a workers' compensation medical condition
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e., Mayo Clinic employees)
  • Workers' compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)
  • Pending application OR Receiving Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI)
  • Self-Employed

Treatment and study plan

RETAIN Program

Other

Facilitates early intervention strategies to support workers in staying-at or returning-to-work (SAW/RTW) after injury or illness and preventing unnecessary disability. This is done by incorporating a Return-to-Work Case Manager as a member of the healthcare clinical team who acts as a liaison for the patient and assists in coordination of referrals between healthcare and Workforce Development services. Return-to-Work Case Managers will interact with treating providers of Minnesota RETAIN intervention group participants to ensure functionally based work restrictions are documented and shared with the patient's employer.

Primary outcomes

  1. Workers to maintain employment

    Time frame: 12 months

    Total number of workers employed at the time of program completion and who have maintained employment 12 months after enrollment.

  2. Reduction on work disability at 1 years

    Time frame: 1 year

    Total number of enrollees that applied for SSDI or SSI during any of the 1 year after enrollment.

  3. Reduction in long term work disability

    Time frame: 5 years

    Total number of enrollees that applied for SSDI or SSI during any of the 5 year after enrollment.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Minnesota Department of Employment and Economic Development
  • Minnesota Department of Health
  • Minnesota Department of Labor and Industry
  • Social Security Administration, The United States
  • United States Department of Labor
  • Workforce Development, Inc.

Registry information

Official study title

Minnesota Retaining Employment and Talent After Injury/Illness Network Phase 2 RETAIN

Acronym: MN RETAIN

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Jan 31, 2022
Registry last updated
May 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.